NewGenIvf (NIVF) Current Deferred Tax Assets (2023)

NewGenIvf (NIVF) posted quarterly Current Deferred Tax Assets of $373677.0 for Q4 2023.

NewGenIvf (NIVF) Current Deferred Tax Assets (2023) Analysis & Trends

NewGenIvf has disclosed Current Deferred Tax Assets across 1 years of filings, most recently posting $373677.0 for Q4 2023.

In Q4 2023, Current Deferred Tax Assets changed N/A year-over-year to $373677.0; the TTM figure through Dec 2023 stood at $373677.0 (changed N/A YoY), while the FY2023 annual figure was $373677.0, changed N/A from the prior year.
Current Deferred Tax Assets held at $373677.0 in Q4 2023.
Over the last five years, Current Deferred Tax Assets for NIVF reached as high as $373677.0 in Q4 2023 and fell as low as $373677.0 in Q4 2023.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	HCA Healthcare	87.94 Bn	90.32 Bn	16.26 Bn
2	Chemed	18.08 Bn	18.07 Bn	215.76 Mn
3	Tenet Healthcare	16.59 Bn	15.76 Bn	4.41 Bn
4	Davita	15.37 Bn	16.23 Bn	1.07 Bn
5	Encompass Health	10.07 Bn	10.70 Bn	1.34 Bn
6	Ensign	9.52 Bn	8.93 Bn	293.37 Mn
7	Universal Health Services	9.19 Bn	9.15 Bn	3.21 Bn
8	Pacs	6.96 Bn	6.72 Bn	345.96 Mn
9	Ww International	6.14 Bn	5.98 Bn	-149.29 Mn
10	NewGenIvf	25,304.95	-1.41 Mn	524,025.00

Historic Data

Download Data

Date	Value
Dec 31, 2023	373,677.00
Dec 31, 2023	373,677.00